(Q28262769)

English

Discovery and preclinical profile of Saxagliptin (BMS-477118): a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes

scientific article

Statements

Discovery and preclinical profile of Saxagliptin (BMS-477118): a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes (English)
0 references
David J Augeri
0 references
Jeffrey A Robl
0 references
David A Betebenner
0 references
David R Magnin
0 references
Ashish Khanna
0 references
James G Robertson
0 references
Aiying Wang
0 references
Ligaya M Simpkins
0 references
Prakash Taunk
0 references
Qi Huang
0 references
Song-Ping Han
0 references
Benoni Abboa-Offei
0 references
Michael Cap
0 references
Li Xin
0 references
Li Tao
0 references
Effie Tozzo
0 references
Gustav E Welzel
0 references
Donald M Egan
0 references
Jovita Marcinkeviciene
0 references
Shu Y Chang
0 references
Scott A Biller
0 references
Mark S Kirby
0 references
Rex A Parker
0 references
Lawrence G Hamann
0 references
28 July 2005
0 references
48
0 references
5025-37
0 references
15
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit